Atwood Kim Cheung

USPTO Granted Patents = 14 (Patent Applications = 8)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 7 (Patent Applications = 6)

Average Co-Inventor Count = 8.9

ph-index = 4

Forward Citations = 64(Granted Patents)

Location History:

Cambridge, MA (US) (2011 - 2016)
Arlington, MA (US) (2012 - 2024)

Company Filing History:

Years Active: 2011-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12157737 - Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof (2024-12-03),

2. 12129246 - Hydroquinazoline derivatives for the treatment of a disease or disorder (2024-10-29),

3. 12084442 - Naphthyridinone derivatives for the treatment of a disease or disorder (2024-09-10),

4. 11708366 - Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof (2023-07-25),

5. 11672799 - 1,4-disubstituted pyridazine quinolne analogs there of and methods for treating SMN-deficiency-related conditions (2023-06-13),

6. 11229648 - 1,4-disubstituted pyridazine analogs thereof and methods for treating SMN-deficiency-related conditions (2022-01-25),

7. 10758533 - 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions (2020-09-01),

8. 10195196 - 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions (2019-02-05),

9. 9545404 - 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions (2017-01-17),

10. 9227982 - 4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrminidinyl compounds for use as tankyrase inhibitors (2016-01-05),

11. 9181266 - 2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors (2015-11-10),

12. 8729263 - 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions (2014-05-20),

13. 8211929 - Pyrimidine derivatives as kinase modulators and method of use (2012-07-03),

14. 8013156 - Tie-2 modulators and methods of use (2011-09-06),

Title: The Innovative Journey of Inventor Atwood Kim Cheung

Introduction:

Atwood Kim Cheung, a prolific inventor based in Arlington, MA, has made significant contributions to the field of pharmaceuticals with his groundbreaking patents. With a total of 11 patents to his name, his work revolves around cutting-edge compounds and their therapeutic applications.

Latest Patents:

Cheung's latest patents showcase his expertise in developing novel pharmaceutical solutions. The first patent, titled "Heteroaryl Substituted Spiropiperidinyl Derivatives and Pharmaceutical Uses Thereof," introduces a compound of formula (I) with promising therapeutic uses. The second patent, "1,4-Disubstituted Pyridazine Quinolone Analogs Thereof and Methods for Treating SMN-Deficiency-Related Conditions," highlights his innovative approach to tackling specific medical conditions.

Career Highlights:

Having garnered experience at renowned companies such as Novartis AG and Exelixis, Inc., Cheung has honed his skills in drug development and research. His time at these esteemed institutions has undoubtedly shaped his innovative thinking and problem-solving abilities.

Collaborations:

In his professional journey, Cheung has collaborated with exceptional individuals in the field, including Donovan Noel Chin and Timothy Brian Hurley. These collaborations have not only enriched his work but have also led to the creation of impactful solutions in the pharmaceutical industry.

Conclusion:

Atwood Kim Cheung's dedication to innovation and scientific advancement is evident through his numerous patents and successful collaborations. His relentless pursuit of developing new therapeutic compounds underscores his commitment to improving healthcare and making a difference in the world of pharmaceuticals. Cheung's work continues to inspire and pave the way for future breakthroughs in the field.

This text is generated by artificial intelligence and may not be accurate.